# Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

> **NCT00535145** · PHASE4 · COMPLETED · sponsor: **Ortho-McNeil Janssen Scientific Affairs, LLC** · enrollment: 121 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Psychotic Disorders

## Interventions

- **DRUG:** Treatment as usual (TAU), Paliperidone ER

## Key facts

- **NCT ID:** NCT00535145
- **Lead sponsor:** Ortho-McNeil Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2014-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00535145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00535145, "Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00535145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*